Hippo Signaling Pathway Regulates Cancer Cell–Intrinsic MHC-II Expression
Zexian Zeng(Peking University), X. Shirley Liu(Harbin Medical University), Nofal Ouardaoui(Dana-Farber Cancer Institute), Shengqing Gu(Dana-Farber Cancer Institute), Lin Yang(Second Affiliated Hospital of Jilin University), Myles Brown(Harvard University), Cheryl J. Wong(Harvard University), Wubing Zhang(California Institute for Regenerative Medicine), Scott J. Rodig(Brigham and Women's Hospital), F. Stephen Hodi(Harvard University), Xiaoqing Wang(Roche (China)), Carly Tymm(Dana-Farber Cancer Institute), Dian Li(Fudan University), Jason L. Weirather(Dana-Farber Cancer Institute)
Cited by 22
Related Papers
Model-based Analysis of ChIP-Seq (MACS)
|Genome biology|2008|20k
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k
Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
|New England Journal of Medicine|2013|3.4k
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
|Genome biology|2016|2.8k